US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
US4452818A
(en)
|
1982-03-19 |
1984-06-05 |
Haidt Sterling J |
Extraocular method of treating the eye with liquid perfluorocarbons
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
AU8192987A
(en)
*
|
1986-12-01 |
1988-06-16 |
Northwestern University |
Human ldh-c4 cdna sequences encoding antigenic regions
|
JPS6452722A
(en)
|
1987-05-01 |
1989-02-28 |
Anjierini Pharmaceut Inc |
Ophthalmic composition
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
US6458376B1
(en)
|
1990-09-27 |
2002-10-01 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery suspensions
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
DE4405627A1
(de)
|
1994-02-22 |
1995-08-24 |
Hoechst Ag |
Fluorkohlenwasserstoffe enthaltende Ölemulsionen
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
US5696164A
(en)
|
1994-12-22 |
1997-12-09 |
Johnson & Johnson Consumer Products, Inc. |
Antifungal treatment of nails
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
DE19536504C2
(de)
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
FR2752161B1
(fr)
|
1996-08-07 |
1998-09-25 |
Atta |
Emulsions multiples de type hydrocarbure-dans-eau-dans- fluorocarbone pour le transport de substances medicamenteuses hydrophiles et/ou lipophiles
|
IN184589B
(ja)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
US5981607A
(en)
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
DK0983037T3
(da)
|
1998-02-09 |
2003-09-01 |
Macrochem Corp |
Fungicid neglelak
|
DE19861012A1
(de)
|
1998-03-18 |
1999-09-30 |
Pharm Pur Gmbh |
Behandlungsmittel für die Ophthalmologie
|
DK1105096T3
(da)
|
1998-08-19 |
2004-03-08 |
Skyepharma Canada Inc |
Injicerbare vandige propofoldispersioner
|
US6140374A
(en)
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
US6159977A
(en)
|
1998-11-16 |
2000-12-12 |
Astan, Inc. |
Therapeutic anti-fungal nail preparation
|
NZ513441A
(en)
|
1999-02-08 |
2004-01-30 |
Alza Corp |
Stable non-aqueous single phase viscous drug delivery vehicles comprising a polymer a solvent and a surfactant
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
EP1124416A1
(en)
|
1999-03-15 |
2001-08-22 |
John Claude Krusz |
Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
|
US6177477B1
(en)
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
DE19926890C1
(de)
|
1999-06-12 |
2000-07-27 |
Pharm Pur Gmbh |
Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
|
DE19938668B4
(de)
|
1999-08-14 |
2006-01-26 |
Bausch & Lomb Inc. |
Tränenersatzmittel
|
JP2001158734A
(ja)
|
1999-12-02 |
2001-06-12 |
Lion Corp |
眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
|
US20030018044A1
(en)
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
US6399087B1
(en)
|
2000-12-20 |
2002-06-04 |
Amphastar Pharmaceuticals, Inc. |
Propofol formulation with enhanced microbial inhibition
|
WO2002089849A1
(en)
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
CZ301310B6
(cs)
|
2001-09-04 |
2010-01-13 |
Trommsdorff Gmbh & Co. Kg Arzneimittel |
Náplast
|
US20040033228A1
(en)
*
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
JP2007503428A
(ja)
|
2003-08-25 |
2007-02-22 |
フォーミックス エルティーディー. |
浸透性医薬発泡剤
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
AU2004293027A1
(en)
|
2003-11-19 |
2005-06-09 |
Barnes-Jewish Hospital |
Enhanced drug delivery
|
GB0408164D0
(en)
*
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
CA2563544A1
(en)
|
2004-04-19 |
2005-10-27 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Lung surfactant supplements
|
US20050288197A1
(en)
|
2004-06-08 |
2005-12-29 |
Ocularis Pharma, Inc. |
Silicone polymer topical eye compositions and methods of use
|
RU2007103835A
(ru)
|
2004-07-01 |
2008-08-10 |
Шепенс Ай Рисерч (Us) |
Композиции и способы лечения заболеваний и нарушений состояния глаз
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
US7740875B2
(en)
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
GB0511499D0
(en)
|
2005-06-06 |
2005-07-13 |
Medpharm Ltd |
Topical ungual formulations
|
AU2006310113A1
(en)
|
2005-08-05 |
2007-05-10 |
Bharat Serums & Vaccines Ltd. |
Intravenous propofol emulsion compositions having preservative efficacy
|
DE102005055811A1
(de)
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
ES2406764T3
(es)
|
2006-06-16 |
2013-06-10 |
Regeneron Pharmaceuticals, Inc. |
Formulaciones que comprenden antagonistas de VEGF para administración intravítrea
|
WO2008060359A2
(en)
|
2006-09-29 |
2008-05-22 |
Surmodics, Inc. |
Biodegradable ocular implants and methods for treating ocular conditions
|
US9000048B2
(en)
|
2006-11-28 |
2015-04-07 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
DE102007055046A1
(de)
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
PT2110126E
(pt)
|
2008-04-18 |
2012-02-20 |
Novaliq Gmbh |
Utilização inalativa e instilativa de alcanos semifluorados como veículos de substância activa na região intrapulmonar
|
US20100000899A1
(en)
*
|
2008-07-07 |
2010-01-07 |
Panasonic Corporation |
Medication blister pack with embedded user interface
|
CA2743824A1
(en)
|
2008-11-26 |
2010-06-03 |
Surmodics, Inc. |
Implantable ocular drug delivery device and methods
|
US8501800B2
(en)
|
2009-03-05 |
2013-08-06 |
Insite Vision Incorporated |
Controlled-release ophthalmic vehicles
|
IT1393419B1
(it)
|
2009-03-19 |
2012-04-20 |
Medivis S R L |
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
|
WO2010146536A1
(en)
|
2009-06-18 |
2010-12-23 |
Koninklijke Philips Electronics N.V. |
Suspension of particles with drug
|
JP5736635B2
(ja)
|
2009-06-25 |
2015-06-17 |
ライオン株式会社 |
ドライアイ治療剤
|
CN102802619A
(zh)
|
2009-06-25 |
2012-11-28 |
狮王株式会社 |
眼科用组合物
|
PT2387391T
(pt)
|
2009-07-24 |
2017-04-20 |
Mika Pharma Ges Für Die Entw Und Vermarktung Pharmazeutischer Produkte Mbh |
Processo para o desenvolvimento de uma composição líquida a ser aplicada na forma de espuma sobre a pele e composição de aplicação tópica
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
CA2792517C
(en)
|
2010-03-09 |
2020-03-24 |
Janssen Biotech, Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
KR101656121B1
(ko)
|
2010-03-17 |
2016-09-08 |
노바리크 게엠베하 |
안압 증가를 치료하기 위한 약학 조성물
|
DE102010022567A1
(de)
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
JP6073244B2
(ja)
|
2011-01-04 |
2017-02-01 |
ノバリック ゲーエムベーハー |
部分フッ素化アルカンを含むo/wエマルション
|
WO2012142670A1
(en)
*
|
2011-04-20 |
2012-10-26 |
The University Of Queensland |
Nuclear magnetic resonance agent
|
JP6023181B2
(ja)
|
2011-05-25 |
2016-11-09 |
ノバリック ゲーエムベーハー |
爪に投与するための医薬組成物
|
AU2012260787B2
(en)
|
2011-05-25 |
2017-02-02 |
Dermaliq Therapeutics, Inc. |
Topical pharmaceutical composition based on semifluorinated alkanes
|
EP2806886B1
(en)
*
|
2012-01-23 |
2017-03-01 |
Novaliq GmbH |
Stabilised protein compositions based on semifluorinated alkanes
|
WO2013173687A1
(en)
|
2012-05-18 |
2013-11-21 |
Genentech, Inc. |
High-concentration monoclonal antibody formulations
|
CN104755073B
(zh)
|
2012-09-12 |
2017-12-26 |
诺瓦利克有限责任公司 |
半氟化烷烃组合物
|
CA2883002C
(en)
|
2012-09-12 |
2019-05-21 |
Novaliq Gmbh |
Compositions comprising mixtures of semifluorinated alkanes
|
TW201427989A
(zh)
|
2012-12-18 |
2014-07-16 |
Novartis Ag |
長效性蛋白質之組合物及方法
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
CN105555311B
(zh)
|
2013-07-23 |
2021-10-08 |
诺瓦利克有限责任公司 |
稳定的抗体组合物
|
EP2944324A1
(de)
|
2014-05-13 |
2015-11-18 |
LTS LOHMANN Therapie-Systeme AG |
Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
|
KR101808234B1
(ko)
|
2015-06-23 |
2017-12-12 |
(주)알테오젠 |
IgG Fc 도메인을 가지는 융합 단백질의 안정한 액상 제제
|
JP6642935B2
(ja)
|
2015-09-30 |
2020-02-12 |
ノバリック ゲーエムベーハー |
眼投与用の半フッ素化化合物
|
DE202016008738U1
(de)
|
2015-09-30 |
2019-04-09 |
Novaliq Gmbh |
Semifluorierte Verbindungen und ihre Zusammensetzungen
|
WO2017087798A1
(en)
|
2015-11-18 |
2017-05-26 |
Formycon Ag |
Pre-filled pharmaceutical package comprising a liquid formulation of a vegf-antagonist
|
CA3010862A1
(en)
|
2016-01-08 |
2017-07-13 |
Clearside Biomedical, Inc. |
Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
|
CN109890374A
(zh)
|
2016-09-22 |
2019-06-14 |
诺瓦利克有限责任公司 |
用于治疗睑缘炎的药物组合物
|
AU2017329983B2
(en)
|
2016-09-23 |
2022-05-05 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
CA3036313A1
(en)
|
2016-09-28 |
2018-04-05 |
Novaliq Gmbh |
Compositions comprising a cannabinoid receptor binding ligand
|
CN116327963A
(zh)
|
2016-11-21 |
2023-06-27 |
济世-伊沃泰克生物制品有限公司 |
一种眼科制剂及其用途
|
CN110248657A
(zh)
|
2016-12-22 |
2019-09-17 |
诺瓦利克有限责任公司 |
用于治疗眼内炎性眼病的包含他克莫司的组合物
|
ES2965883T3
(es)
|
2016-12-23 |
2024-04-17 |
Novaliq Gmbh |
Composición oftálmica para el tratamiento de la enfermedad del ojo seco
|
WO2020165132A1
(en)
|
2019-02-13 |
2020-08-20 |
Novaliq Gmbh |
Compositions and methods for the treatment of ocular neovascularization
|
WO2021105392A1
(en)
|
2019-11-27 |
2021-06-03 |
Novaliq Gmbh |
Suspension comprising a protein particle suspended in a non-aqueous vehicle
|